Literature DB >> 33499843

Effect of 4DryField® PH on blood loss in hip bipolar hemiarthroplasty following intracapsular femoral neck fracture - a randomized clinical trial.

Benjamin Lucas1, Christian Riebau2, Juliane Mohr2, Gerald Pliske2, Felix Walcher2, Stefan Piatek2.   

Abstract

BACKGROUND: One of the most common complications of hip arthroplasty is excessive blood loss that could necessitate allogenic blood transfusion, which is further associated with other complications, such as infections, transfusion reactions or immunomodulation. In gynecology, 4DryField®PH, an absorbable polysaccharide-based formulation, is used for hemostasis and adhesion prophylaxis. In this study, we evaluated its hemostatic effect in patients undergoing hip bipolar hemiarthroplasty following intracapsular femoral neck fracture.
METHODS: We studied 40 patients with intracapsular femoral neck fractures (Garden III or IV) admitted at our institution between July 2016 and November 2017. We included patients above 60 years with simple fracture and without pathologic fractures. Patients were randomized into intervention and control groups. The intervention group received 5 g of 4DryField® PH (subfascially and subcutaneously) during wound closure. Three drainages were inserted in a standardized manner (submuscular, subfascial, and subcutaneous) and drainage volume was measured immediately before extraction. Total blood loss was calculated using Mercuriali's formula and standard hemograms upon admission and five days after surgery. Volume of postoperative hematoma was measured using point-of-care ultrasound seven days after surgery.
RESULTS: Volume of the postoperative hematoma was reduced by 43.0 mL. However, significant reduction of total blood loss and drainage volume was not observed.
CONCLUSIONS: We observed that 4DryField® PH had a local hemostatic effect, thereby reducing volume of the postoperative hematoma. However, this reduction was small and had no effect on the total blood loss. Further studies are warranted to improve the application algorithm. TRIAL REGISTRATION: DRKS, DRKS00017452 , Registered 11 June 2019 - Retrospectively registered.

Entities:  

Keywords:  4DryField® PH; Blood loss; Femoral neck fractures; Hip arthroplasty

Mesh:

Year:  2021        PMID: 33499843      PMCID: PMC7836593          DOI: 10.1186/s12891-021-03983-6

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  22 in total

1.  Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis.

Authors:  Jeffrey Yates; Iris Perelman; Simonne Khair; Joshua Taylor; Jacinthe Lampron; Alan Tinmouth; Elianna Saidenberg
Journal:  Transfusion       Date:  2018-12-05       Impact factor: 3.157

2.  Preoperative factors and early complications associated with hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures.

Authors:  Christopher P Miller; Rafael A Buerba; Michael P Leslie
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-06

Review 3.  Transfusion reactions: prevention, diagnosis, and treatment.

Authors:  Meghan Delaney; Silvano Wendel; Rachel S Bercovitz; Joan Cid; Claudia Cohn; Nancy M Dunbar; Torunn O Apelseth; Mark Popovsky; Simon J Stanworth; Alan Tinmouth; Leo Van De Watering; Jonathan H Waters; Mark Yazer; Alyssa Ziman
Journal:  Lancet       Date:  2016-04-12       Impact factor: 79.321

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  The transgluteal approach to the hip joint.

Authors:  R Bauer; F Kerschbaumer; S Poisel; W Oberthaler
Journal:  Arch Orthop Trauma Surg       Date:  1979-10

Review 6.  Total joint replacement and blood loss: what is the best equation?

Authors:  Emmanuel Gibon; Jean-Pierre Courpied; Moussa Hamadouche
Journal:  Int Orthop       Date:  2013-02-06       Impact factor: 3.075

7.  The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: A randomized clinical trial.

Authors:  Guorui Cao; Zeyu Huang; Jinwei Xie; Qiang Huang; Bin Xu; ShaoYun Zhang; FuXing Pei
Journal:  Thromb Res       Date:  2018-02-15       Impact factor: 3.944

Review 8.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.

Authors:  Katharine Ker; Phil Edwards; Pablo Perel; Haleema Shakur; Ian Roberts
Journal:  BMJ       Date:  2012-05-17

9.  Lymphostasis and Hemostasis in Body-Contouring Surgery Using a Polysaccharide Based Hemostat (4DryField PH).

Authors:  Mona Rudolph; Peter M Vogt; Klaus Müller; Tobias R Mett
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-03-25

10.  Optimal use of tranexamic acid for total hip arthroplasty: A network meta-analysis.

Authors:  Byung-Ho Yoon; Tae-Young Kim; Young Seung Ko; Young-Kyun Lee; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.